The Clinic Curative Study Of Curing The Cough Variant Asthma(CVA) With Cold Syndrome Due To The Deficiency By The Therapy Of Wenfeihuatanyin

Objective:To explore the clinic curative of wenfeihuatanyin treating children Cough Variant Asthma with feelble cold syndrome. and probe into its function mechanism tentatively.Method:60 patients of CVA with feelble cold syndrome were randomly divided into the treatment group and control group,30 patients in each group.the treatment group give wenfeihuatanyin to drink, control group give the oral aminophylline simply, The clinical therapeutic effect and change of the absolute eosinophile count (EOS) and T cell’s in peripheral blood before and after treatment were observed, and compared between the two group streating one week later.Result:In clinical research the general effective rate in treatment group and control group was respeetively 83.3% and 86.7% and there was no statistieally difference, But two groups have remarkable statistics meanings to improve the difference to the overall Chinese medicine symptom (P<0.01), Also the treatment group surpasses the control group. wenfeihuatanyin reduces the absolute eosinophile count (EOS)(P<0.01) in peripheral blood and T cell (P<0.05)of CVA with cold syndrome efficiently,and there was a significant difference as compared to the control group.Conclusion:The therapeutic effect of wenfeihuatanyin is certain. Maybe the wenfeihuatanyin has better functions of cough-relief,resolving nasal obstruction, cold body, and low toxicity,reduces the absolute EOS count in peripheral blood and improve the effect of T cell efficiently,and can be used as an effective and safe traditional Chinese medicine to treat patients in CVA with feelble cold syndrome.